• About us
• Contact

Advertisement

Organisation › Details

SVB Leerink LLC

SVB Leerink is a leading investment bank, specializing in healthcare and life sciences. The firm’s knowledge, experience and focus enable it to help its clients define and achieve their strategic, capital markets and investment objectives. SVB Leerink partners with companies that develop and commercialize innovative products and services that are defining the future of healthcare. SVB Leerink is a wholly-owned subsidiary of SVB Financial Group and is a member of FINRA/SIPC. *

 

	Start	2018-11-13 renamed date ca
	End	2022-02-01 renamed
	Group	Leerink Partners (Group)
	Today	Leerink Partners (Group)
	Successor	SVB Securities LLC
	Industry	investment banking
	Industry 2	LIFE SCIENCES
	Region	Boston, MA
	Country	United States (USA)
	Street	One Federal Street
	City	02110 Boston, MA
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Leerink Partners LLC. (1/4/19). "Press Release: SVB Financial Group Completes Acquisition of Healthcare Investment Bank Leerink Partners". Santa Clara, CA.
		Record changed: 2024-01-12

Advertisement

More documents for Leerink Partners (Group)

• [1] MoonLake Immunotherapeutics AG. (6/28/23). "Press Release: MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares". Zug....
• [2] MoonLake Immunotherapeutics AG. (6/26/23). "Press Release: MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering". Zug....
• [3] Hookipa Pharma Inc.. (5/31/23). "Press Release: Hookipa Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock". New York, NY & Vienna....
• [4] Bruker Corporation. (2/22/21). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA....
• [5] Immunic, Inc.. (8/10/20). "Press Release: Immunic, Inc. Announces Closing of $103.5 Million Public Offering, including Full Exercise of Underwriters’ Option to Purchase Additional Shares". New York, NY....
• [6] Immunic, Inc.. (8/5/20). "Press Release: Immunic, Inc. Announces Pricing of $90.0 Million Public Offering of Common Stock". New York, NY....
• [7] Molecular Partners AG. (7/6/20). "Press Release: Molecular Partners Announces the Launch of a Private Placement of Shares by Way of an Accelerated Bookbuilding". Zürich-Schlieren....
• [8] BioNTech SE. (10/10/19). "Press Release: BioNTech Announces Pricing of Initial Public Offering". Mainz....
• [9] CureVac AG. (2/19/19). "Press Release: CureVac to Present at the 8th Annual Leerink Partners Global Healthcare Conference". Tübingen & Boston, MA....
• [10] Bruker Corporation. (2/9/18). "Press Release: Bruker Corporation to Present at the Leerink Partners 7th Annual Global Healthcare Conference". Billerica, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.